Contract Pharma

EU Selects SK bioscience, IDT Biologika, Vaxxas for Next-Gen Flu Vaccine Development

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.
Yahoo Finance

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public ...

Ethris Part of Consortium to Receive up to EUR 148 Million European Commission Contract to Advance Novel Pandemic Influenza Vaccine

Unlike traditional systemic vaccines, the mRNA vaccine under evaluation is designed to trigger a robust immune response directly at the site of influenza entry, with potential to reduce viral ...

SK Bioscience secures first EU vaccine project with IDT

SK Bioscience said Thursday it has secured its first European Union-backed vaccine development project alongside German subsidiary IDT Biologika, marking a key ...
Kotaku

HyperNova: Escape from Hadea

All the Latest Game Footage and Images from HyperNova: Escape from Hadea HyperNova: Escape from Hadea: a charming open world single-player RTS with quirky characters, beautiful planetary design and a ...